ADVANCED SOLID TUMOUR
Clinical trials for ADVANCED SOLID TUMOUR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOUR trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOUR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink hard-to-treat cancers
Disease control Recruiting nowThis study tests whether a new drug called LBL-024, when combined with other medicines, can shrink or control advanced solid tumors. About 140 adults aged 18 to 75 with advanced cancer will receive the treatment. The main goal is to see how many patients' tumors shrink or disappe…
Matched conditions: ADVANCED SOLID TUMOUR
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
New drug cocktail shows promise against tough cancers
Disease control Recruiting nowThis study tests a new drug called LBL-024 combined with other medicines in 230 adults with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination can shrink tumors or stop them from growing. Participants will receive the drug …
Matched conditions: ADVANCED SOLID TUMOUR
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug combo aims to shrink tough tumors
Disease control Recruiting nowThis study tests a new drug called LBL-024 combined with other medicines in about 110 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to see if the combination can shrink tumors or stop them from growing. Participants will receiv…
Matched conditions: ADVANCED SOLID TUMOUR
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New combo therapy aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests a new drug called LBL-024 combined with other medicines in 110 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to see if the combination can shrink tumors or stop them from growing. Participants will receive the …
Matched conditions: ADVANCED SOLID TUMOUR
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 19, 2026 12:00 UTC